stockportfolio.pro
The Chemours Company Revenue 2013–2025
The Chemours Company (CC) annual revenue by fiscal year, computed from SEC filings. Compound growth -1.4%/yr over 12 years.
| Fiscal year | Revenue | Change (YoY) |
|---|---|---|
| FY 2025 | $5.81B | +0.4% |
| FY 2024 | $5.78B | -4.1% |
| FY 2023 | $6.03B | -11.3% |
| FY 2022 | $6.79B | +7.1% |
| FY 2021 | $6.34B | +27.7% |
| FY 2020 | $4.97B | -10.1% |
| FY 2019 | $5.53B | -16.8% |
| FY 2018 | $6.64B | +7.4% |
| FY 2017 | $6.18B | +14.5% |
| FY 2016 | $5.40B | -5.5% |
| FY 2015 | $5.72B | -11.1% |
| FY 2014 | $6.43B | -6.2% |
| FY 2013 | $6.86B | — |
Source: The Chemours Company SEC filings — income statement (10-K). Refreshed nightly.
See the full picture for The Chemours Company
Complete income statement, balance sheet and cash flow with trend on every row, 48 quarters, ratios, health checks, and Ask — the SEC-grounded research assistant.
Open the interactive view — freeThe Chemours Company — frequently asked questions
What is The Chemours Company's revenue?
The Chemours Company (CC) reported revenue of $5.81B for fiscal year 2025, per its SEC filings.
How has The Chemours Company's revenue changed over time?
Between fiscal 2013 and 2025, CC's revenue declined at roughly 1.4% per year (compound annual rate), from $6.86B to $5.81B.
Where does this data come from?
Figures are computed from The Chemours Company's official SEC filings (income statement (10-K)), refreshed nightly. Not investment advice.